AN OXIDIZED ANALOG OF ALPHA-HUMAN ATRIAL NATRIURETIC POLYPEPTIDE IS A SELECTIVE AGONIST FOR THE ATRIAL-NATRIURETIC-POLYPEPTIDE CLEARANCE RECEPTOR WHICH LACKS A GUANYLATE-CYCLASE

被引:13
作者
KOYAMA, S [1 ]
TERAI, T [1 ]
INOUE, T [1 ]
INOMATA, K [1 ]
TAMURA, K [1 ]
KOBAYASHI, Y [1 ]
KYOGOKU, Y [1 ]
KOBAYASHI, M [1 ]
机构
[1] OSAKA UNIV,INST PROT RES,SUITA,OSAKA 565,JAPAN
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1992年 / 203卷 / 03期
关键词
D O I
10.1111/j.1432-1033.1992.tb16566.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The differences in biological functions between alpha-human atrial natriuretic polypeptide (alpha-hANP) and its oxidized analog, MetSO-alpha-hANP, have been investigated. Analysis of the ANP receptor subtypes by affinity labeling has shown that a bovine pulmonary aortic endothelial cell line (CPAE cells) primarily expresses ANP-R1 (R, receptor) coupled to particulate guanylate cyclase, while Hela cells from human cervical carcinoma predominantly express ANP-R2, which lacks a guanylate cyclase. alpha-hANP could bind to both ANP receptor subtypes with high affinity, while MetSO-alpha-hANP showed more selective binding to ANP-R2 than to ANP-R1. The activity of MetSO-alpha-hANP for stimulation of guanylate cyclase coupled to ANP-R1 was about 520-fold less than that of alpha-hANP (median effective dose = 2.5 nM for alpha-hANP, 1.3-mu-M for MetSO-alpha-hANP), indicating that MetSO-alpha-hANP was a partial agonist for this receptor. While this oxidized analog could inhibit the cAMP production through ANP-R2 with 0.15 times the activity of alpha-hANP (median concentration = 0.31 nM for alpha-hANP, 2.0 nM for MetSO-alpha-hANP). In in vivo studies, the diuretic activity of MetSO-alpha-hANP was 25-100-fold less than that of alpha-hANP. In addition, MetSO-alpha-hANP could potentiate the diuretic activity of alpha-hANP that was also caused by C-ANF4-23, a specific agonist for ANP-R2. These results demonstrate that MetSO-alpha-hANP can act as an agonist more selective for ANP-R2 than for ANP-R1, both in vivo and in vitro. The relationship between receptor selectivities and the conformation of alpha-hANP or MetSO-alpha-hANP was also discussed.
引用
收藏
页码:425 / 432
页数:8
相关论文
共 27 条
[1]  
ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566
[2]   IDENTIFICATION OF STRUCTURAL REQUIREMENTS FOR ANALOGS OF ATRIAL NATRIURETIC PEPTIDE (ANP) TO DISCRIMINATE BETWEEN ANP RECEPTOR SUBTYPES [J].
BOVY, PR ;
ONEAL, JM ;
OLINS, GM ;
PATTON, DR .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (04) :869-874
[3]   DIVERSE BIOLOGICAL ACTIONS OF ATRIAL-NATRIURETIC-PEPTIDE [J].
BRENNER, BM ;
BALLERMANN, BJ ;
GUNNING, ME ;
ZEIDEL, ML .
PHYSIOLOGICAL REVIEWS, 1990, 70 (03) :665-699
[4]   DIFFERENTIAL ACTIVATION BY ATRIAL AND BRAIN NATRIURETIC PEPTIDES OF 2 DIFFERENT RECEPTOR GUANYLATE CYCLASES [J].
CHANG, M ;
LOWE, DG ;
LEWIS, M ;
HELLMISS, R ;
CHEN, E ;
GOEDDEL, DV .
NATURE, 1989, 341 (6237) :68-72
[5]   A MEMBRANE FORM OF GUANYLATE-CYCLASE IS AN ATRIAL NATRIURETIC PEPTIDE RECEPTOR [J].
CHINKERS, M ;
GARBERS, DL ;
CHANG, MS ;
LOWE, DG ;
CHIN, HM ;
GOEDDEL, DV ;
SCHULZ, S .
NATURE, 1989, 338 (6210) :78-83
[6]   MULTIPLE RANGE AND MULTIPLE F TESTS [J].
DUNCAN, DB .
BIOMETRICS, 1955, 11 (01) :1-42
[7]  
FETHIERE J, 1989, MOL PHARMACOL, V35, P584
[8]  
FULLER F, 1988, J BIOL CHEM, V263, P9395
[9]  
GELDERN TWV, 1990, MOL PHARMACOL, V38, P771
[10]   Y-1 ADRENOCORTICAL TUMOR-CELLS CONTAIN ATRIAL NATRIURETIC PEPTIDE RECEPTORS WHICH REGULATE CYCLIC-NUCLEOTIDE METABOLISM AND STEROIDOGENESIS [J].
HEISLER, S ;
TALLERICOMELNYK, T ;
YIP, C ;
SCHIMMER, BP .
ENDOCRINOLOGY, 1989, 125 (05) :2235-2243